Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiaowei Zhang
Institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
Observed institutions:
Shanghai Medical College of Fudan University,
Fudan University,
Fudan University Shanghai Cancer Center
ORCID:
0000-0002-7054-9061
Observed ORCID:
0000-0002-7054-9061
OpenAlex ID:
A5082974374
Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2022
·
Xin Liu
, Shiyu Jiang
, et al.
·
Clinical Cancer Research
·
38
Sintilimab, doxorubicin and ifosfamide (AI) as first-line treatment in patients with advanced undifferentiated pleomorphic sarcoma (UPS), synovial sarcoma (SS), myxoid liposarcoma (MLPS) and de-differentiated liposarcoma (DDLPS): A single-arm phase 2 trial.
2024
·
Xin Liu
, Yanjing Guo
, et al.
·
Journal of Clinical Oncology
·
9
Advancements in Diagnostics and Therapeutics for Cancer of Unknown Primary in the Era of Precision Medicine
2025
·
Ting Zhao
, Xiaowei Zhang
, et al.
·
MedComm
·
6
PDF
Fruquintinib as first‐line or second‐line treatment in unresectable or metastatic soft‐tissue sarcoma: A prospective, single‐arm phase II study
2025
·
Xiaowei Zhang
, Ting Zhao
, et al.
·
Clinical and Translational Medicine
·
2
PDF
Supplementary Data TS1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2025
·
Xin Liu
, Shiyu Jiang
, et al.
PDF
Figure S1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2025
·
Xin Liu
, Shiyu Jiang
, et al.
PDF
Data from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
Supplementary Data TS1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
Figure S1 from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
PDF
Data from Pegylated Liposomal Doxorubicin Combined with Ifosfamide for Treating Advanced or Metastatic Soft-tissue Sarcoma: A Prospective, Single-arm Phase II Study
2023
·
Xin Liu
, Shiyu Jiang
, et al.
Show more works
View as search
Works count:
10
Citation count:
55
H-index:
3
I10-index:
1
Year
Topic
Type